TY - JOUR
T1 - Fok-I vitamin D receptor gene polymorphism (rs10735810) and vitamin D metabolism in multiple sclerosis
AU - Smolders, Joost
AU - Damoiseaux, Jan
AU - Menheere, Paul
AU - Tervaert, Jan Willem Cohen
AU - Hupperts, Raymond
PY - 2009/2/15
Y1 - 2009/2/15
N2 - Multiple sclerosis (MS) has been associated with low levels of 25-hydroxyvitamin D (25(OH)D). Several genetic polymorphisms of the vitamin D receptor gene (VDRG), of whom Fok-I (rs10735810) has functional consequences for receptor protein structure and the immune system, have been studied in relation to MS with variable results. The purpose of our study was to assess an association of the Fok-I VDRG polymorphism with MS, and to further unravel the interaction of this polymorphism with vitamin D metabolism. Therefore, we genotyped 212 MS patients and 289 healthy controls for the Fok-I polymorphism and determined levels of the vitamin D metabolites 25(OH)D and 1,25(OH)2D. No association of the Fok-I VDRG polymorphism with MS was found. The F-allele was associated with lower winter and summer serum 25(OH)D levels in our MS patients, and with lower 25(OH)D levels in healthy controls. Remarkably, the F-allele corresponded with higher 1,25(OH)2D levels in MS patients. In all groups, carriers of the F-allele had higher 1,25(OH)2D/ 25(OH)D-ratios compared to their f-allele counterparts. In conclusion, we demonstrated the importance of the Fok-I VDRG polymorphism for vitamin D metabolism. This should be taken into account in association and ultimately intervention studies on vitamin D and MS.
AB - Multiple sclerosis (MS) has been associated with low levels of 25-hydroxyvitamin D (25(OH)D). Several genetic polymorphisms of the vitamin D receptor gene (VDRG), of whom Fok-I (rs10735810) has functional consequences for receptor protein structure and the immune system, have been studied in relation to MS with variable results. The purpose of our study was to assess an association of the Fok-I VDRG polymorphism with MS, and to further unravel the interaction of this polymorphism with vitamin D metabolism. Therefore, we genotyped 212 MS patients and 289 healthy controls for the Fok-I polymorphism and determined levels of the vitamin D metabolites 25(OH)D and 1,25(OH)2D. No association of the Fok-I VDRG polymorphism with MS was found. The F-allele was associated with lower winter and summer serum 25(OH)D levels in our MS patients, and with lower 25(OH)D levels in healthy controls. Remarkably, the F-allele corresponded with higher 1,25(OH)2D levels in MS patients. In all groups, carriers of the F-allele had higher 1,25(OH)2D/ 25(OH)D-ratios compared to their f-allele counterparts. In conclusion, we demonstrated the importance of the Fok-I VDRG polymorphism for vitamin D metabolism. This should be taken into account in association and ultimately intervention studies on vitamin D and MS.
UR - http://www.scopus.com/inward/record.url?scp=60149088668&partnerID=8YFLogxK
U2 - 10.1016/j.jneuroim.2008.12.011
DO - 10.1016/j.jneuroim.2008.12.011
M3 - Article
C2 - 19178954
AN - SCOPUS:60149088668
SN - 0165-5728
VL - 207
SP - 117
EP - 121
JO - Journal of Neuroimmunology
JF - Journal of Neuroimmunology
IS - 1-2
ER -